Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands |
Jun. 30, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Balance Sheet Related Disclosures [Abstract] | ||
| Accrued nonclinical, clinical and process development costs | $ 10,402 | $ 4,401 |
| Employee compensation | 7,213 | 9,540 |
| Accrued professional services | 704 | 554 |
| Other | 926 | 1,125 |
| Total accrued expenses and other current liabilities | $ 19,245 | $ 15,620 |
| X | ||||||||||
- Definition Accrued expenses and other current liabilities. No definition available.
|
| X | ||||||||||
- Definition Accrued preclinical clinical and development process costs. No definition available.
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|